TCRX: TScan Therapeutics Inc
TCRX exchange rate has changed by -0.88% for today. During the day, the instrument was traded at a low of 1.09 and at a high of 1.16.
Follow TScan Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TCRX News
- Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
- Tscan Therapeutics stock holds Neutral rating at BTIG after ASH event
- TScan to host KOL event discussing updated ALLOHA trial data
- Morgan Stanley downgrades Tscan Therapeutics stock on delayed trials
- Tscan Therapeutics earnings beat by $0.06, revenue topped estimates
- TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Lags Revenue Estimates
- Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates
- Novavax (NVAX) Reports Q3 Loss, Beats Revenue Estimates
- Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates
- BTIG downgrades Tscan Therapeutics stock to Neutral on program delays
- This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Civitas Resources (NYSE:CIVI), Alvotech (NASDAQ:ALVO)
- Tscan Therapeutics stock plunges after pausing solid tumor trial enrollment
- TScan to focus on heme program, cuts workforce by 30% amid FDA progress
- Alnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates
- Tracking Baker Brothers Portfolio – Q2 2025 Update
- TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates
- Tscan Therapeutics earnings beat by $0.05, revenue topped estimates
- Urogen Pharma (URGN) Reports Q2 Loss, Lags Revenue Estimates
- Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates
- Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
- TScan Therapeutics elects directors and ratifies auditor at annual meeting
- Tracking Baker Brothers Portfolio – Q1 2025 Update
Frequently Asked Questions
What is TCRX stock price today?
TScan Therapeutics Inc stock is priced at 1.12 today. It trades within 1.09 - 1.16, yesterday's close was 1.13, and trading volume reached 598. The live price chart of TCRX shows these updates.
Does TScan Therapeutics Inc stock pay dividends?
TScan Therapeutics Inc is currently valued at 1.12. Dividend policy depends on the company, while investors also watch -55.56% and USD. View the chart live to track TCRX movements.
How to buy TCRX stock?
You can buy TScan Therapeutics Inc shares at the current price of 1.12. Orders are usually placed near 1.12 or 1.42, while 598 and 1.82% show market activity. Follow TCRX updates on the live chart today.
How to invest into TCRX stock?
Investing in TScan Therapeutics Inc involves considering the yearly range 0.88 - 2.67 and current price 1.12. Many compare 12.00% and -34.12% before placing orders at 1.12 or 1.42. Explore the TCRX price chart live with daily changes.
What are TScan Therapeutics Inc stock highest prices?
The highest price of TScan Therapeutics Inc in the past year was 2.67. Within 0.88 - 2.67, the stock fluctuated notably, and comparing with 1.13 helps spot resistance levels. Track TScan Therapeutics Inc performance using the live chart.
What are TScan Therapeutics Inc stock lowest prices?
The lowest price of TScan Therapeutics Inc (TCRX) over the year was 0.88. Comparing it with the current 1.12 and 0.88 - 2.67 shows potential long-term entry points. Watch TCRX moves on the chart live for more details.
When did TCRX stock split?
TScan Therapeutics Inc has gone through stock splits historically. These changes are visible in , 1.13, and -55.56% after corporate actions.
- Previous Close
- 1.13
- Open
- 1.10
- Bid
- 1.12
- Ask
- 1.42
- Low
- 1.09
- High
- 1.16
- Volume
- 598
- Daily Change
- -0.88%
- Month Change
- 12.00%
- 6 Months Change
- -34.12%
- Year Change
- -55.56%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- 0.0%
- Prev
- 0.2%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- 4.798%